Roland Arnold

Also affiliated with Cancer Research UK Clinical Trials Unit, University of Birmingham

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID‐19: disease control as an important factor relative to recent chemotherapy or anti‐CD20 therapy”.

Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID‐19: disease control as an important factor relative to recent chemotherapy or anti‐CD20 therapy

British Journal of Haematology(2022)10.1111/bjh.17937

N/A

0.550DataRank · unranked

38 citations

Helen Curley, Csilla Varnai, Roland Arnold, Lennard Y. W. Lee, Naomi A. Campton +30 more

Genetic evaluation of CRISPR-Cas9 off-target effects from deleterious mutations on Drosophila male single X chromosome

Functional & Integrative Genomics(2025)10.1007/s10142-025-01775-y

N/A

0DataRank · unranked

1 citations

David W. J. McQuarrie, Irmgard U. Haussmann, Roland Arnold, Matthias Soller, Wei Bian